BLACK DIAMOND THERAPEUTICS INC. - COMMON STOCK

Black Diamond Therapeutics Announces Strategic Priorities and Expected Milestones for 2022

10 1 2022 07:00:02 提供 Nasdaq GlobeNewswire

Black Diamond Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

05 1 2022 08:00:02 提供 Nasdaq GlobeNewswire

Black Diamond Therapeutics to Present at Upcoming Investor Conferences

08 11 2021 16:05:02 提供 Nasdaq GlobeNewswire

Black Diamond Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update

08 11 2021 07:45:00 提供 Nasdaq GlobeNewswire

Black Diamond Therapeutics Presents Preclinical Data on BDTX-1535, BRAF, and FGFR Programs at the 33rd AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

08 10 2021 16:05:00 提供 Nasdaq GlobeNewswire

Black Diamond Therapeutics to Present Pre-Clinical Data on BDTX-1535, BRAF, and FGFR Programs at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

30 9 2021 16:35:00 提供 Nasdaq GlobeNewswire

Black Diamond Therapeutics to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference

21 9 2021 16:05:00 提供 Nasdaq GlobeNewswire

Black Diamond Therapeutics and OpenEye Scientific Announce Collaboration to Expand MAP Drug Discovery Platform

21 9 2021 07:45:00 提供 Nasdaq GlobeNewswire

Black Diamond Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update

12 8 2021 08:22:20 提供 Nasdaq GlobeNewswire

Black Diamond Therapeutics Announces Appointment of Mark Velleca, M.D., Ph.D. to Board of Directors

10 8 2021 07:45:00 提供 Nasdaq GlobeNewswire

Black Diamond Therapeutics to Present at Upcoming Investor Conferences

04 8 2021 07:45:00 提供 Nasdaq GlobeNewswire

Black Diamond Therapeutics Presents Phase 1 Pharmacokinetic, Safety, and Preliminary Efficacy Data of BDTX-189 in Advanced Solid Tumors Harboring EGFR or HER2 Alterations

19 5 2021 17:00:00 提供 Nasdaq GlobeNewswire

Black Diamond Therapeutics to Host Webcast Presentation of Data From Phase 1 Dose-Escalation Portion of MasterKey-01 Clinical Trial

17 5 2021 07:45:00 提供 Nasdaq GlobeNewswire

Black Diamond Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update

07 5 2021 07:45:00 提供 Nasdaq GlobeNewswire

Black Diamond Therapeutics to Present Phase 1 BDTX-189 Data in Advanced Solid Tumors at American Society of Clinical Oncology

28 4 2021 10:38:27 提供 Nasdaq GlobeNewswire

Black Diamond Therapeutics Announces Preclinical Data Presentations on BDTX-189 and BDTX-1535 at American Association for Cancer Research Annual Meeting

10 4 2021 08:30:00 提供 Nasdaq GlobeNewswire

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

25 3 2021 07:45:00 提供 Nasdaq GlobeNewswire

Black Diamond Therapeutics to Present Pre-Clinical Data on BDTX-189 and BDTX-1535 at American Association for Cancer Research Annual Meeting

10 3 2021 16:58:50 提供 Nasdaq GlobeNewswire

Black Diamond Therapeutics Announces Pre-Clinical Data Presentations on New Programs Targeting BRAF and FGFR at ESMO TAT Virtual Congress 2021

02 3 2021 16:05:00 提供 Nasdaq GlobeNewswire

Black Diamond Therapeutics to Present at Upcoming Investor Conferences

23 2 2021 07:45:00 提供 Nasdaq GlobeNewswire